The effect of soil pH on rhizosphere carbon flow of Lolium perenne

Perennial rye-grass plants were grown at 15°C in microcosms containing soil sampled from field plots that had been maintained at constant pH for the last 30 years. Six soil pH values were tested in the experiment, with pH ranging from 4.3-6.5. After 3 weeks growth in the microcosms, plant shoots were exposed to a pulse of ¹⁴C-CO₂. The fate of this label was determined by monitoring ¹⁴C-CO₂ respired by the plant roots/soil and by the shoots. The ¹⁴C remaining in plant roots and shoots was determined when the plants were harvested 7 days after receiving the pulse label. The amount of ¹⁴C (expressed as a percentage of the total ¹⁴C fixed by the plant) lost from the plant roots increased from 12.3 to 30.6% with increasing soil pH from 4.3 to 6. Although a greater percentage of the fixed ¹⁴C was respired by the root/soil as soil pH increased, plant biomass was greater with increasing soil pH. Possible reasons for observed changes in the pattern of ¹⁴C distribution are discussed and, it is suggested that changes in the soil microbial biomass and in plant nitrogen nutrition may, in particular be key factors which led to increased loss of carbon from plant roots with increasing soil pH. © 1990 Kluwer Academic Publishers.

Carbon distribution within the plant and rhizosphere for Lolium perenne subjected to anaerobic soil conditions

Perennial ryegrass was subjected to a range of anaerobic treatments. The distribution of C within the plant was determined by pulse labelling the shoots with ¹⁴C-CO₂. A 5 h anaerobic period before pulse labelling reduced by 2.5-10 times the ¹⁴C remaining in the plants and released into the soil. The distribution of the ¹⁴C within the plant was also affected by anaerobiosis. Short periods of anaerobiosis (5 or 10 h) led to increased root-soil ¹⁴C respiration (monitored for 7 days). A longer period of anaerobiosis (48 h) initially inhibited root-soil ¹⁴C respiration, but when aerobiosis was restored. 57% of the total ¹⁴C fixed by the plant was respired by the roots-soil during the following 7 days compared to 19% for the aerobic control. There was a two-thirds reduction in the percentage C retained by the plants stressed for the 48 h compared to the aerobic control. At harvest, all anaerobic treatments were associated with more ¹⁴C remaining in the soil as a proportion of the total ¹⁴C fixed by the plant compared to the aerobic control. © 1990.

GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF

The severe combined immunodeficient (SCID) mouse model may be used to evaluate new approaches for the treatment of acute myeloid leukemia (AML). We have previously demonstrated the killing of SCID mouse leukemia initiating cells by in vitro incubation with human GM-CSF fused to Diphtheria toxin (DT-huGM-CSF). In this report, we show that in vivo treatment with DT-huGM-CSF eliminates AML growth in SCID mice. Seven cases of AML were studied. SCID mice were treated intraperitoneally with the maximally tolerated dose of 75 microg/kg/day for 7 days. Antileukemic efficacy was determined at days 40 and 80 after transplantation, by enumerating the percentages of human cells in SCID bone marrow using flow cytometry and short tandem repeat polymerase chain reaction (STR-PCR) analysis. Four out of seven AML cases were sensitive to in vivo treatment with DT-huGM-CSF at both evaluation time points. In three of these cases, elimination of human cells was demonstrated by flow cytometry and STR-PCR. One AML case showed moderate sensitivity for DT-huGM-CSF, and growth of the two remaining AML cases was not influenced by DT-huGM-CSF. Sensitivity was correlated with GM-CSFR expression. Our data show that DT-huGM-CSF can be used in vivo to reduce growth of AML and warrant further development of DT-huGM-CSF for the treatment of human AML.

Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors

We have evaluated the effect of in vivo Campath-1G on engraftment and GVHD in 23 patients with severe aplastic anaemia transplanted from HLA-identical sibling donors. In 14 patients Campath 1g was given pre-transplant for up to 9 days in an attempt to overcome graft rejection (group 1). In nine patients Campath-1G was given pre-transplant, but also continued post-transplant until day +5 to reduce GVHD (group 2). There were three patients with late graft failure in group I following initial neutrophil engraftment, and four cases of grade II+ GVHD. In group II, two patients had early graft failure (no take), and there were no cases of acute GVHD out of seven evaluable patients. One patient in group I developed chronic GVHD of the liver, and two patients (one in each group) had transient localised chronic GVHD. PCR of short tandem repeats was used to evaluate chimaeric status in 13 patients. Of 11 patients with initial neutrophil engraftment, only one had 100% donor haemopoiesis at all times. The remaining patients had either transient mixed chimaerism or persistence of recipient (< 20%) cells. We conclude that in vivo Campath-1G is associated with a high incidence of mixed chimaerism which tips the balance away from GVHD but towards graft rejection.

Improving a regional chemotherapy service by learning from deaths occurring within 30 days of treatment with systemic anti-cancer therapy.

Background: Outwith clinical trials, patient outcomes specifically related to SACT (systemic anti-cancer therapy) are not well reported despite a significant proportion of patients receiving active treatment at the end of life. The NCEPOD reviewing deaths within 30 days of SACT found SACT caused or hastened death in 27% of cases.

Method: Across the Northern Ireland cancer network, 95 patients who died within 30 days of SACT for solid tumours were discussed at the Morbidity and Mortality monthly meeting during 2013. Using a structured template, each case was independently reviewed, with particular focus on whether SACT caused or hastened death.

Results: Lung, GI and breast cancers were the most common sites. Performance status was recorded in 92% at time of final SACT cycle (ECOG PS 0-2 89%).

In 57% the cause of death was progressive disease. Other causes included thromboembolism (13%) and infection (5% neutropenic sepsis, 6% non-neutropenic sepsis). In 26% with death from progressive disease, the patient was first cycle of first line treatment for metastatic disease. In the majority discussion regarding treatment aims and risks was documented. Only one patient was receiving SACT with curative intent, who died from appropriately managed neutropenic sepsis.

A definitive decision regarding SACT's role in death was made in 60%: in 49% SACT was deemed non-contributory and in 11% SACT was deemed the cause of death. In 40% SACT did not play a major role, but a definitive negative association could not be made.

Conclusion: Development of a robust review process of 30-day mortality after SACT established a benchmark for SACT delivery for future comparisons and identified areas for SACT service organisation improvement. Moreover it encourages individual practice reflection and highlights the importance of balancing patients' needs and concerns with realistic outcomes and risks, particularly in heavily pre-treated patients or those of poor performance status.

Ophthalmology. 2011 Dec;118(12):2343-50. doi: 10.1016/j.ophtha.2011.06.016. Epub 2011 Sep 1. Randomized, controlled trial of an educational intervention to promote spectacle use in rural China: the see well to learn well study.

OBJECTIVE: To test an educational intervention promoting the purchase of spectacles among Chinese children. DESIGN: Randomized, controlled trial. PARTICIPANTS: Children in years 1 and 2 of all 20 junior and senior high schools (ages 12-17 years) in 3 rural townships in Guangdong, China. METHODS: Children underwent visual acuity (VA) testing, and parents of participants with presenting VA worse than 6/12 in either eye improving by more than 2 lines with cycloplegic refraction were recommended to purchase glasses. Children at 10 randomly selected schools received a lecture, video, and classroom demonstration promoting spectacle purchase. MAIN OUTCOME MEASURES: Self-reported purchase of spectacles (primary outcome) and observed wear or possession of newly purchased glasses (secondary outcome) at follow-up examinations (mean, 219 ± 87 days after the baseline visit). RESULTS: Among 15 404 eligible children, examinations were completed for 6379 (74.6%) at intervention schools and 5044 (73.6%) at control schools. Spectacles were recommended for 2236 (35.1%) children at intervention schools and for 2212 (43.9%) at control schools. Of these, 417 (25.7%) intervention schools children and 537 (34.0%, P = 0.45) control schools children reported buying glasses. Predictors of purchase in regression models included female gender (P = 0.02), worse uncorrected VA (P < 0.001), and higher absolute value of refractive error (P = 0.001). Neither the rate of self-reported purchase of glasses or observed wear or possession of newly purchased glasses differed between control schools and intervention schools in mixed-effect logistic regression models. Among children not purchasing glasses, 21.7% had better-eye VA of worse than 6/18. CONCLUSIONS: An intervention based on extensive pilot testing and focus groups in the area failed to promote spectacle purchase or wear. The high burden of remaining uncorrected poor vision underscores the need to develop better interventions. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review

BACKGROUND: Care of critically ill patients in intensive care units (ICUs) often requires potentially invasive or uncomfortable procedures, such as mechanical ventilation (MV). Sedation can alleviate pain and discomfort, provide protection from stressful or harmful events, prevent anxiety and promote sleep. Various sedative agents are available for use in ICUs. In the UK, the most commonly used sedatives are propofol (Diprivan(®), AstraZeneca), benzodiazepines [e.g. midazolam (Hypnovel(®), Roche) and lorazepam (Ativan(®), Pfizer)] and alpha-2 adrenergic receptor agonists [e.g. dexmedetomidine (Dexdor(®), Orion Corporation) and clonidine (Catapres(®), Boehringer Ingelheim)]. Sedative agents vary in onset/duration of effects and in their side effects. The pattern of sedation of alpha-2 agonists is quite different from that of other sedatives in that patients can be aroused readily and their cognitive performance on psychometric tests is usually preserved. Moreover, respiratory depression is less frequent after alpha-2 agonists than after other sedative agents.

OBJECTIVES: To conduct a systematic review to evaluate the comparative effects of alpha-2 agonists (dexmedetomidine and clonidine) and propofol or benzodiazepines (midazolam and lorazepam) in mechanically ventilated adults admitted to ICUs.

DATA SOURCES: We searched major electronic databases (e.g. MEDLINE without revisions, MEDLINE In-Process & Other Non-Indexed Citations, EMBASE and Cochrane Central Register of Controlled Trials) from 1999 to 2014.

METHODS: Evidence was considered from randomised controlled trials (RCTs) comparing dexmedetomidine with clonidine or dexmedetomidine or clonidine with propofol or benzodiazepines such as midazolam, lorazepam and diazepam (Diazemuls(®), Actavis UK Limited). Primary outcomes included mortality, duration of MV, length of ICU stay and adverse events. One reviewer extracted data and assessed the risk of bias of included trials. A second reviewer cross-checked all the data extracted. Random-effects meta-analyses were used for data synthesis.

RESULTS: Eighteen RCTs (2489 adult patients) were included. One trial at unclear risk of bias compared dexmedetomidine with clonidine and found that target sedation was achieved in a higher number of patients treated with dexmedetomidine with lesser need for additional sedation. The remaining 17 trials compared dexmedetomidine with propofol or benzodiazepines (midazolam or lorazepam). Trials varied considerably with regard to clinical population, type of comparators, dose of sedative agents, outcome measures and length of follow-up. Overall, risk of bias was generally high or unclear. In particular, few trials blinded outcome assessors. Compared with propofol or benzodiazepines (midazolam or lorazepam), dexmedetomidine had no significant effects on mortality [risk ratio (RR) 1.03, 95% confidence interval (CI) 0.85 to 1.24, I (2) = 0%; p = 0.78]. Length of ICU stay (mean difference -1.26 days, 95% CI -1.96 to -0.55 days, I (2) = 31%; p = 0.0004) and time to extubation (mean difference -1.85 days, 95% CI -2.61 to -1.09 days, I (2) = 0%; p < 0.00001) were significantly shorter among patients who received dexmedetomidine. No difference in time to target sedation range was observed between sedative interventions (I (2) = 0%; p = 0.14). Dexmedetomidine was associated with a higher risk of bradycardia (RR 1.88, 95% CI 1.28 to 2.77, I (2) = 46%; p = 0.001).

LIMITATIONS: Trials varied considerably with regard to participants, type of comparators, dose of sedative agents, outcome measures and length of follow-up. Overall, risk of bias was generally high or unclear. In particular, few trials blinded assessors.

CONCLUSIONS: Evidence on the use of clonidine in ICUs is very limited. Dexmedetomidine may be effective in reducing ICU length of stay and time to extubation in critically ill ICU patients. Risk of bradycardia but not of overall mortality is higher among patients treated with dexmedetomidine. Well-designed RCTs are needed to assess the use of clonidine in ICUs and identify subgroups of patients that are more likely to benefit from the use of dexmedetomidine.

STUDY REGISTRATION: This study is registered as PROSPERO CRD42014014101.

FUNDING: The National Institute for Health Research Health Technology Assessment programme. The Health Services Research Unit is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates.

Diversity and biology of polychaeta of Diopatra Genus

Os anelídeos poliquetas são elementos importantes em ambientes estuarinos e costeiros, pela sua elevada biodiversidade e abundância e pelo papel que têm nas cadeias tróficas. Algumas espécies são intensivamente exploradas para serem utilizadas como isco na pesca desportiva e profissional, como é o caso de Diopatra neapolitana. Apesar da importância económica, existem poucos estudos sobre a sua biologia e ecologia. No decorrer deste estudo foram identificadas duas outras espécies do género Diopatra em Portugal: D. marocensis, inicialmente descrita para a costa de Marrocos e cuja distribuição actual se sabe estender-se a toda a costa Portuguesa e Norte de Espanha e, D. micrura, espécie nova para a ciência. O presente estudo tem como objectivos principais estudar a diversidade e reprodução do género Diopatra, bem como a capacidade de regeneração da espécie D. neapolitana. Este trabalho aborda a distribuição espacial de D. marocensis ao longo da costa Portuguesa e descreve a espécie D. micrura, uma nova espécie do género Diopatra Audouin and Milne Edwards, 1833. As três espécies coabitam em águas transicionais, onde as espécies D. micrura e D. marocensis facilmente se confundem com juvenis de D. neapolitana. Foi realizada uma comparação morfológica e genética entre as três espécies. A espécie D. neapolitana coexiste em algumas áreas da Ria de Aveiro com a D. marocensis. Apesar destas duas espécies apresentarem padrões reprodutivos muito diferentes, Maio a Agosto é o período principal para a reprodução de ambas as espécies. D. neapolitana apresenta um desenvolvimento larvar planctónico, e os óocitos presentes na cavidade celómica são esverdeados e apresentam um diâmetro de 40-240 μm (média = 164.39±40.79 μm) e as fêmeas contêm no celoma milhares de óocitos. Contrariamente, a espécie D. marocensis reproduz-se por desenvolvimento directo no interior do tubo parental. Os óocitos observados no celoma são amarelos com um diâmetro entre 180 e 740 μm (média = 497.65 ± 31.38 μm) e o seu número varia entre 44 e 624 (276.85 ± 161.54). Por seu turno, o número de ovos observados no interior dos tubos varia entre 75 e 298, com um diâmetro entre 600 e 660 μm, e o número de larvas entre 60 e 194. A proporção machos: fêmeas foi de 1:1 para a população de D. neapolitana e entre 1:2 e 1:4 para a população de D. marocensis, em que as fêmeas dominam a população durante todo o ano. O estudo da capacidade de regeneração da espécie D. neapolitana, avaliada a partir de experiências de laboratório, revelou que esta espécie é capaz de sobreviver à perda de alguns setígeros. Durante a captura de D. neapolitana para vender como isco são normalmente cortados mais de 20 setígeros e de acordo com os nossos resultados a extremidade posterior que fica no tubo não é capaz de regenerar a extremidade anterior; a espécie consegue no entanto recuperar de ataques por predadores.

Distribuição por tamanhos do aerosol atmosférico na Península Ibérica

Um dos principais fatores que afetam negativamente a qualidade do ambiente em muitas cidades em todo o mundo é o material particulado (PM). A sua presença na atmosfera pode ter impactos negativos na saúde humana, clima, património edificado e ecossistemas. Muitos dos estudos realizados em áreas urbanas focam apenas as frações respiráveis (PM10 e PM2,5). No entanto, os processos de formação, a identificação das fontes emissoras e os efeitos dependem muito da distribuição granulométrica das partículas. A atenção tem recaído na análise de hidrocarbonetos poliaromáticos (PAHs), devida à sua carcinogenicidade e a informação disponível sobre outros compostos é escassa. O presente estudo consistiu na obtenção do PM distribuído por diferentes frações de tamanho e na análise detalhada da sua composição química, em dois locais urbanos da Península Ibérica (Madrid e Lisboa). Dado que os veículos representam uma das principais fontes emissoras em ambientes urbanos, efetuou-se uma caracterização mais detalhada deste tipo de emissões, conduzindo uma campanha de amostragem num túnel rodoviário (Marquês de Pombal, Lisboa). As amostragens, em ambas as cidades, decorreram durante um mês, quer no verão quer no inverno, em dois locais urbanos distintos, um junto a uma via com influência de tráfego e outro numa área urbana de fundo. No túnel a amostragem foi realizada apenas durante uma semana. Em Madrid e no túnel, o PM foi recolhido utilizando um amostrador de elevado volume com impactor em cascata com quatro tamanhos: 10-2,5, 2,5-0,95, 0,95-0,49 e < 0,49 μm. Em Lisboa, foi utilizado um impactor em cascata com apenas dois tamanhos, 10- 2,5 e < 2,5 μm. As amostras foram quimicamente analisadas e determinadas as concentrações de compostos carbonados (OC, EC e carbonatos), iões inorgânicos solúveis em água (Cl−, NO3−, SO42−, Na+, NH4+, K+, Mg2+, Ca2+),metais e compostos orgânicos. Em Madrid, as concentrações médias de PM10 foram 44 e 48% maiores nas amostras recolhidas junto à estrada do que as de fundo urbano no verão e inverno, respetivamente. A fração grosseira e o PM0,5 apresentaram concentrações mais elevadas no verão do que no inverno devido às condições climatéricas pouco usuais. No verão, as amostragens decorreram num mês em que as temperaturas foram muito elevadas e em que ocorreram vários episódios de intrusão de poeira africana. Durante o período de amostragem de inverno, as temperaturas foram muito baixas e registaram-se vários dias de precipitação quer sob a forma de chuva, quer sob a forma de neve. As situações meteorológicas sinóticas mais comuns, incluindo aquelas que causam o transporte de massas de ar com poeiras Africanas, foram identificadas em ambas as estações do ano. As concentrações mássicas de PM10, EC e OC foram encontrados predominantemente na fração de tamanho ultrafino em ambos os locais de amostragem e estações do ano. Nas restantes frações não se observou nenhuma tendência sazonal. O carbono orgânico secundário (SOC) mostrou um claro padrão sazonal, com concentrações muito mais elevadas no verão do que no inverno, em ambos os lugares. A partir do balanço mássico de iões, observou-se que, no verão, a formação de compostos inorgânicos secundários (SIC) conduziu a um enriquecimento pouco comum de Ca2+ na fração submicrométrica, quer nas amostras de tráfego, quer em fundo urbano. Os alcanos, PAHs, os álcoois e os ácidos foram as classes de compostos orgânicos identificados e quantificados no material particulado. Globalmente, representaram 0,26 e 0,11 μg m−3 no verão e inverno, respetivamente, no local de tráfego e 0,28 e 0,035 μg m−3 na área urbana de fundo. Os diferentes compostos orgânicos também apresentaram padrões sazonais, sugerindo fontes de emissão (e.g. escapes dos veículos e fontes biogénicas) ou processos de formação com contribuições variáveis ao longo do ano. As concentrações de benzoapireno equivalente foram menores que 1 ng m-3 e o risco carcinogénico estimado é baixo. No verão, os maiores enriquecimentos de metais ocorreram na fração submicrométrica, e no inverno na fração grosseira. No verão, os enriquecimentos foram ≥ 80% para o Mn, Ni, Cu, Zn, Cd, Sb e Co, no inverno, estes traçadores de emissões do tráfego foram menores, exceto para o Zn. Em Lisboa, a concentração média de PM10 foi de 48 μg m-3 no verão e de 44 μg m-3 no inverno, junto à estrada. Na área de fundo urbano, registaram-se níveis comparáveis nas duas estações (27 μg m-3 e 26 μg m-3). A média do rácio PM2,5/PM10 foi de 65% no verão e 44% no inverno na área de tráfego e 62% e 59% na área urbana de fundo. Estes resultados significam que o PM2,5 é um dos principais contaminantes que afetam a qualidade do ar no centro da cidade de Lisboa. A relação OC/EC, que reflete a composição das emissões de combustão dos veículos, variou entre 0,3 e 0,4 no interior do túnel. Os rácios de OC/EC mínimos obtidos junto às vias de tráfego em Madrid e em Lisboa encontram-se entre os do túnel e os registados em atmosferas urbanas de fundo, sugerindo que os valores mínimos habitualmente obtidos para este parâmetro em ambientes urbanos abertos sobrestimam as emissões diretas de OC pelo transporte rodoviário. Espera-se que os resultados deste trabalho contribuam para suprir, pelo menos em parte, as lacunas de informação quer sobre a composição de várias granulometrias de PM, quer sobre fontes e processos de formação em atmosferas urbanas. Como a exposição a poluentes do ar ultrapassa o controle dos indivíduos e exige ação das autoridades públicas a nível nacional, regional e até mesmo internacional, é importante propor medidas mitigadoras focadas nas principais fontes de emissão identificadas.

Penn Center Heritage Days

This proclamation from Governor Mark Sanford proclaims November 8 – 14, 2004 as Penn Center Heritage Days.

South Carolina/common pleas court circuits meeting benchmark 80% of Pending Docket 365 Days or Less From Placement on the Trial Docket as of February 28, 2015

This is a list of the courts in all the circuits of South Carolina and the percentage of cases disposed of in 365 day or less. Only three courts met the 80% benchmark.

South Carolina/general sessions court circuits meeting benchmark : 80% of pending docket 365 days or less as of February 28, 2015

This document provides statistics on criminal and general sessions courts meeting the benchmark of 80% of pending dockets broken down by circuits and counties.

South Carolina/family court circuits meeting benchmark : 80% of pending docket 365 days or less as of February 28, 2015

This is a diagram broken down by circuits of the percentage of family courts meeting the benchmark of 80% of disposing of cases within a year.